Related Experiment Videos
Receptor-mediated immunomodulation by corticotropin-releasing factor
T Audhya1, R Jain, C S Hollander
1Department of Medicine, New York University Medical Center, NY 10016.
Cellular Immunology
|April 15, 1991
Summary
Corticotropin-releasing factor (CRF) binds to immune cells, suppressing their function. This study confirms CRF
Area of Science:
- Immunology
- Neuroendocrinology
Background:
- Corticotropin-releasing factor (CRF) is implicated in stress responses and immune modulation.
- Previous studies suggest CRF influences immune function, but specific cellular targets were unclear.
Purpose of the Study:
- To investigate the direct binding of CRF to human immune cells.
- To elucidate the functional consequences of CRF binding on immune cell activity.
- To confirm the role of CRF in immunomodulation.
Main Methods:
- CRF binding assays on human monocyte-macrophages and T-lymphocytes.
- Measurement of intracellular cyclic AMP (cAMP) levels following CRF exposure.
- Assessment of rat splenocyte proliferation in response to interleukin-2 (IL-2) with and without CRF.
- Use of CRF antagonists to block CRF effects.
Main Results:
- Specific binding sites for CRF were identified on human monocyte-macrophages and T-helper lymphocytes.
- CRF binding led to increased intracellular cAMP concentrations in these cells.
- CRF inhibited IL-2-induced rat splenocyte proliferation, an effect reversed by CRF antagonists.
- CRF did not bind to T-suppressor or B lymphocytes.
Conclusions:
- CRF possesses specific receptors on key immunocytes, including monocyte-macrophages and T-helper lymphocytes.
- CRF binding modulates immune cell function, evidenced by cAMP production and suppressed proliferation.
- These findings strengthen the evidence for CRF's significant role in neuroendocrine-immune interactions and immunomodulation.